Last Updated on Friday, 13 December 2013 19:06Written by Kevin KerriganThursday, 12 December 2013 18:40
(c) Guam News – Guam News
Guam – No representatives from the Guam medical Association turned out for the Thursday evening hearing on the medicinal marijuana bill, but GMA did submit written testimony opposing the measure.
This was the second public hearing on Bill #215 which was introduced by Senator Tina Muna-Barnes and co-sponsored by Senator Aline Yamashita.
The written testimony was submitted by GMA Executive Director Pram Sullivan and it states that the Board of the GMA is“unable to support Bill 215-32 as written.”
Among the points GMA makes in opposition to the bill are:
– The Federal Drug Enforcement Agency (DEA) have stated that “Organizer behind the “medical” marijuana movement have not dealt with ensuring that the product meets the standards of modern medicine: quality, safety and efficacy.
– The National Multiple Sclerosis Society (NMSS) has stated that it could not recommend medical marijuana be made widely available for people with multiple sclerosis for symptom management, explaining: “This decision was not only based on existing legal barriers to its use but, even more importantly, because studies to date do not demonstrate a clear benefit
– The American Glaucoma Society (AGS) has stated that “although marijuana can lower the intraocular pressure, the side effects and short duration of action, coupled with the lack of evidence that its use alters the course of glaucoma, preclude recommending this drug in any form for the treatment of glaucoma at the present time.”